Literature DB >> 18792031

Langerhans cells and viral immunity.

Anthony L Cunningham1, Francis Carbone, Teunis B H Geijtenbeek.   

Abstract

Langerhans cells (LC) are a unique dendritic cell subset that are located in mucosal stratified squamous epithelium and skin epidermis. Their location is ideally suited for their function as antigen presenting cells that capture invading viruses and induce anti-viral immunity. However, it is becoming evident that the interaction between LC and viruses can result in different responses, depending on the virus and the receptors involved. Here we will discuss the recent data on the similarities and differences in roles of LC in viral immunity to and infection with HIV, herpes simplex and varicella-zoster virus. Although all three viruses interact with LC during initial infection, the effects can be quite different, reflecting differences in biology and pathogenesis.

Entities:  

Mesh:

Year:  2008        PMID: 18792031     DOI: 10.1002/eji.200838521

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  25 in total

1.  Langerin, the "Catcher in the Rye": an important receptor for pathogens on Langerhans cells.

Authors:  Patrizia Stoitzner; Nikolaus Romani
Journal:  Eur J Immunol       Date:  2011-09       Impact factor: 5.532

Review 2.  The role of human dendritic cells in HIV-1 infection.

Authors:  Zahra Ahmed; Tatsuyoshi Kawamura; Shinji Shimada; Vincent Piguet
Journal:  J Invest Dermatol       Date:  2014-11-19       Impact factor: 8.551

3.  Biology of mucosally transmitted sexual infection-translating the basic science into novel HIV intervention: a workshop summary.

Authors:  Damian Purcell; Anthony Cunningham; Stuart Turville; Gilda Tachedjian; Alan Landay
Journal:  AIDS Res Hum Retroviruses       Date:  2012-10-10       Impact factor: 2.205

Review 4.  Microneedle-mediated vaccine delivery: harnessing cutaneous immunobiology to improve efficacy.

Authors:  Sharifa Al-Zahrani; Marija Zaric; Cian McCrudden; Chris Scott; Adrien Kissenpfennig; Ryan F Donnelly
Journal:  Expert Opin Drug Deliv       Date:  2012-04-05       Impact factor: 6.648

Review 5.  Human Immunodeficiency Virus Immune Cell Receptors, Coreceptors, and Cofactors: Implications for Prevention and Treatment.

Authors:  Andrew W Woodham; Joseph G Skeate; Adriana M Sanna; Julia R Taylor; Diane M Da Silva; Paula M Cannon; W Martin Kast
Journal:  AIDS Patient Care STDS       Date:  2016-07       Impact factor: 5.078

6.  Suppression of Langerhans cell activation is conserved amongst human papillomavirus α and β genotypes, but not a µ genotype.

Authors:  Diane M Da Silva; Carly A Movius; Adam B Raff; Heike E Brand; Joseph G Skeate; Michael K Wong; W Martin Kast
Journal:  Virology       Date:  2014-02-17       Impact factor: 3.616

7.  Circumcision plus antibiotic, anti-inflammatory, and α-blocker therapy for the treatment for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, multicenter trial.

Authors:  Yuyang Zhao; Wei Zhao; Genqiang Lang; Yaowu Chen; Jianxin Liu; Guozeng Wang; Xiaobing Ma; Min Gong; Dongliang Xu; Shujie Xia
Journal:  World J Urol       Date:  2014-07-01       Impact factor: 4.226

Review 8.  A two-step model for Langerhans cell migration to skin-draining LN.

Authors:  Eduardo J Villablanca; Jorge R Mora
Journal:  Eur J Immunol       Date:  2008-11       Impact factor: 5.532

9.  Inflammatory conditions distinctively alter immunological functions of Langerhans-like cells and dendritic cells in vitro.

Authors:  André Said; Stephanie Bock; Gerrit Müller; Günther Weindl
Journal:  Immunology       Date:  2015-02       Impact factor: 7.397

10.  A role for the JAK-STAT1 pathway in blocking replication of HSV-1 in dendritic cells and macrophages.

Authors:  Kevin R Mott; David Underhill; Steven L Wechsler; Terrence Town; Homayon Ghiasi
Journal:  Virol J       Date:  2009-05-13       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.